Hemogenyx Pharmaceuticals receives FDA nod for HEMO-CAR-T AML treatment study

Hemogenyx Pharmaceuticals plc, a London-based biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) to proceed with its Phase I clinical ... Read More